Peer-Reviewed Publication FIRST HOSPITAL OF JILIN UNIVERSITY ANTITUMOUR NECROSIS FACTOR ALPHA (ANTI-TNFΑ) AGENTS INCLUDE INFLIXIMAB, ADALIMUMAB, GOLIMUMAB, AVX-470 AND OPRX-106. JANUS KINASE (JAK) INHIBITORS: TOFACITINIB, FILGOTINIB AND UPADACITINIB. CYTOKINE INHIBITORS: USTEKINUMAB, WHICH TARGETS INTERLEUKIN (IL) 12, SUBUNIT P40/P35; RISANKIZUMAB, MIRIKIZUMAB, GUSELKUMAB AND BRAZIKUMAB TARGET IL-23, SUBUNIT P40/P19. SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR MODULATORS: AMISELIMOD, OZANIMOD, ETRASIMOD AND...